Krystal Biotech buy Chardan Capital
Start price
18.02.26
/
50%
€240.80
Target price
18.02.27
€272.68
Performance (%)
-7.77%
Price
17.03.26
€222.10
Summary
This prediction is currently active. With a performance of -7.77%, the BUY prediction by Chardan_Capital is trending in the wrong direction. This prediction currently runs until 18.02.27. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Krystal Biotech | -1.157% |
| iShares Core DAX® | -0,68 % |
| iShares Nasdaq 100 | -0,03 % |
| iShares Nikkei 225® | -0,54 % |
| iShares S&P 500 | -0,21 % |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Chardan Capital from $220.00 to $323.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€170.15
04.11.25
04.11.25
€191.16
04.11.26
04.11.26
30.53%
17.03.26
17.03.26
Krystal Biotech
Start price
Target price
Perf. (%)
€127.05
22.08.25
22.08.25
€186.08
22.08.26
22.08.26
74.81%
17.03.26
17.03.26
Krystal Biotech
Start price
Target price
Perf. (%)
€118.80
05.08.25
05.08.25
€189.46
05.08.26
05.08.26
86.95%
17.03.26
17.03.26
Krystal Biotech
Start price
Target price
Perf. (%)
€125.75
25.07.25
25.07.25
€186.52
25.07.26
25.07.26
76.62%
17.03.26
17.03.26
Krystal Biotech
Start price
Target price
Perf. (%)
€116.70
07.05.25
07.05.25
€193.05
07.05.26
07.05.26
90.32%
17.03.26
17.03.26
Krystal Biotech
Start price
Target price
Perf. (%)
€172.25
20.02.25
20.02.25
€208.60
20.02.26
20.02.26
27.14%
21.02.26
21.02.26
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
30.09%
19.12.25
19.12.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
25.47%
13.12.25
13.12.25

